Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIPARK: Opicapone in Parkinson's Disease
NCT02847442Phase 4Completed
- Sponsor
- BIAL
- Start
- Nov 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Nov 2016; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02847442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847442.